Cell death: protein misfolding and neurodegenerative diseases

被引:140
|
作者
Nakamura, Tomohiro [1 ]
Lipton, Stuart A. [1 ,2 ]
机构
[1] Burnham Inst Med Res, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA
[2] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92039 USA
关键词
S-Nitrosylation; Molecular chaperone; Ubiquitin-proteasome system; Protein misfolding; Neurodegeneration; NITRIC-OXIDE SYNTHASE; ENDOPLASMIC-RETICULUM STRESS; METHYL-D-ASPARTATE; UBIQUITIN LIGASE ACTIVITY; PARKINS PROTECTIVE FUNCTION; DISULFIDE-ISOMERASE FAMILY; LONG-TERM POTENTIATION; NMDA RECEPTOR-ACTIVITY; LEWY-BODY FORMATION; S-NITROSYLATION;
D O I
10.1007/s10495-008-0301-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several chronic neurodegenerative disorders manifest deposits of misfolded or aggregated proteins. Genetic mutations are the root cause for protein misfolding in rare families, but the majority of patients have sporadic forms possibly related to environmental factors. In some cases, the ubiquitin-proteasome system or molecular chaperones can prevent accumulation of aberrantly folded proteins. Recent studies suggest that generation of excessive nitric oxide (NO) and reactive oxygen species (ROS), in part due to overactivity of the NMDA-subtype of glutamate receptor, can mediate protein misfolding in the absence of genetic predisposition. S-Nitrosylation, or covalent reaction of NO with specific protein thiol groups, represents one mechanism contributing to NO-induced protein misfolding and neurotoxicity. Here, we present evidence suggesting that NO contributes to protein misfolding via S-nitrosylating protein-disulfide isomerase or the E3 ubiquitin ligase parkin. We discuss how memantine/NitroMemantine can inhibit excessive NMDA receptor activity to ameliorate NO production, protein misfolding, and neurodegeneration.
引用
收藏
页码:455 / 468
页数:14
相关论文
共 50 条
  • [31] Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases
    Martin, Lee J.
    PHARMACEUTICALS, 2010, 3 (04): : 839 - 915
  • [32] Protein Misfolding Diseases
    Hartl, F. Ulrich
    ANNUAL REVIEW OF BIOCHEMISTRY, VOL 86, 2017, 86 : 21 - 26
  • [33] Targeting programmed cell death in neurodegenerative diseases
    Miquel Vila
    Serge Przedborski
    Nature Reviews Neuroscience, 2003, 4 : 365 - 375
  • [34] Targeting programmed cell death in neurodegenerative diseases
    Vila, M
    Przedborski, S
    NATURE REVIEWS NEUROSCIENCE, 2003, 4 (05) : 365 - 375
  • [35] Neuronal cell death and apoptosis in neurodegenerative diseases
    Klockgether, T
    Wüllmer, U
    PARKINSON'S DISEASE, 2002, 1 : 81 - 87
  • [36] Apoptotic cell death in neuroinflammatory and neurodegenerative diseases
    Gold, R
    Stadelmann, C
    Brück, W
    Lassmann, H
    AKTUELLE NEUROLOGIE, 2001, 28 (01) : 17 - 25
  • [37] Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases
    Hekmatimoghaddam, Seyedhossein
    Zare-Khormizi, Mohamad Reza
    Pourrajab, Fatemeh
    BIOFACTORS, 2017, 43 (06) : 737 - 759
  • [38] The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases
    Winklhofer, Konstanze F.
    Tatzelt, Joerg
    Haass, Christian
    EMBO JOURNAL, 2008, 27 (02): : 336 - 349
  • [39] Bridging the gap: From protein misfolding to protein misfolding diseases
    Luheshi, Leila M.
    Dobson, Christopher M.
    FEBS LETTERS, 2009, 583 (16): : 2581 - 2586
  • [40] S-Nitrosylation of Critical Protein Thiols Mediates Protein Misfolding and Mitochondrial Dysfunction in Neurodegenerative Diseases
    Nakamura, Tomohiro
    Lipton, Stuart A.
    ANTIOXIDANTS & REDOX SIGNALING, 2011, 14 (08) : 1479 - 1492